An HPB Commemoration: Pancreas Cancer Center Progress Update — On Demand

Friday, December 29, 2023, 9:00 AM - Monday, September 30, 2024, 11:00 PM

The Memorial Sloan Kettering HPB Commemoration was a three-part event held live, in-person on November 30 through December 2, 2023, highlighting the remarkable progress made in the management of patients with HPB malignancies over recent years, resulting in enhanced outcomes and prolonged survival. The event honored the legacy of Dr. Leslie H. Blumgart, celebrated the remarkable career of Dr. Nancy E. Kemeny, and delivered a comprehensive update on the latest developments from the David M. Rubenstein Center for Pancreatic Cancer Research. We are delighted to extend an on demand option for the Pancreas Cancer Center Progress Update as well as the Nancy E. Kemeny, MD Celebratory Symposium.

The Pancreas Cancer Center Progress Update provides an update on research advances from the David M. Rubenstein Center for Pancreatic Cancer Research and showcases the state-of-the-science in pancreas adenocarcinoma. The program will begin with the David M. Rubenstein Award Lecture, presented by Andrew M. Lowy, MD, FACS of University of California San Diego. Following this lecture, faculty will showcase current and novel therapeutic approaches in this disease with a vision to the future.

On Demand Content

In purchasing this on demand, you'll receive access to video recordings, PDFs of the speakers' presentations (slides), and recorded Q&A/panel discussions for the following sessions topics:

• David M. Rubenstein Award Lecture
  • Linking Actin Dynamics and Transcriptional Control to Pancreatic Cancer Biology (Andrew Lowy, MD)
• Epidemiology & Biology of Pancreas Cancer
  • Changing Epidemiology of PDAC
  • Pathology, Sub-types, and More
  • Rubenstein Center, Molecular Landscape of PDAC
• Hot Topics in Pancreas Cancer
  • Optimal Imaging for PDAC
  • Surgical Innovation in PDAC
  • Case Presentation and Panel Discussion
  • Novel Therapies in PDAC Beyond KRAS
  • Next Generation Immunotherapy for PDAC
  • KRAS Therapy for PDAC: Current and the Future

Target Audience

The content featured in this on demand is intended for medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists, pharmacists, supportive care staff, advanced practice practitioners, nurses, trainees, and other disciplines.

1. Implement recent advances in pancreatic cancer research

Upon successful registration, access to the course materials, including instructions for claiming credit, is located under the 'Course Content' tab. This on demand program will be available for purchase until June 30, 2024. For those that purchase this on demand, access to the content, as well as the opportunity to claim credit, is available through September 30, 2024.

On Demand Access Fees

• Physicians (MDs, PhDs, and DOs): $100
• Pharmacists, Nurses, and Other Healthcare Providers: $100
• Advanced Practice Providers: $75
• Residents and Resident: complimentary*
• MSK Employees: complimentary

*Residents and Fellows: Registration is required in order to access this on demand program. Please submit your request here for a complimentary promotion code to be applied during registration.

MSK Alumni and MSK Cancer Alliance Members: A discounted registration rate is offered to MSK Alumni and MSK Cancer Alliance members for all MSK CME programs. If you belong to either of these groups, please submit your request here to receive a promotion code to be applied at registration. Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

MSK Employees: MSK employees can register for any CME program on a complimentary basis. Employees need to log in to the MSK CME Portal using their SS0 login credentials and register for the desired program.  

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Recorded/Review Date: December 1, 2023 | Original Release Date: December 29, 2023 | Termination Date: September 30, 2024

MSK Symposium Directors 

William R. Jarnagin, MD, FACS
Leslie Blumgart Chair in Surgery
Chief, Hepatopancreatobiliary Service
Department of Surgery 

Andrea Cercek, MD
Section Head, Colorectal Cancer
Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers
Associate Attending
Gastrointestinal Oncology Service
Department of Medicine

Michael I. D'Angelica, MD, FACS
Attending 
Hepatopancreatobiliary Service
Department of Surgery 

Christine A. Iacobuzio-Donahue, MD, PhD
Director, David M. Rubenstein Center for Pancreatic Cancer Research
Attending
Department of Pathology

Yelena Y. Janjigian, MD
Chief, Gastrointestinal Oncology Service
Department of Medicine

T. Peter Kingham, MD, FACS
Director, Global Cancer Disparities Initiatives
Attending
Hepatopancreatobiliary Service
Department of Surgery 

Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head, Hepatopancreaticobiliary and Neuroendocrine Cancers
Co-Director of Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer
Attending, Member
Department of Medicine 
Professor of Medicine, Weill Cornell Medical College

 

Invited Faculty

Andrew Lowy, MD
Professor of Surgery
Levine Family Chancellor’s Endowed Chair in Surgical Oncology 
Chief, Division of Surgical Oncology
Associate Clinical Director, Surgery
Moores Cancer Center, University of California, San Diego 
La Jolla, CA

 

MSK Faculty 

Vinod P. Balachandran, MD 
Assistant Attending
Hepatopancreatobiliary Service
Department of Surgery
Assistant Member, Human Oncology and Pathogenesis Program

Olca Basturk, MD
Attending 
Gastrointestinal and Pancreatobiliary Pathology
Department of Pathology and Laboratory Medicine

Richard Kinh Gian Do, MD, PhD
Attending
Body Imaging Service 
Department of Radiology
Professor of Radiology, Weill Cornell Medical College

Mengmeng (Margaret) Du, ScD, MSc
Associate Attending
Department of Epidemiology & Biostatistics

Christine A. Iacobuzio-Donahue, MD, PhD
Director, David M. Rubenstein Center for Pancreatic Cancer Research
Attending
Department of Pathology

Marion Liu, MD
Chief Surgical Oncology Fellow
Hepatopancreatobiliary Service
Department of Surgery 

Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head, Hepatopancreaticobiliary and Neuroendocrine Cancers
Co-Director of Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer
Attending, Member
Department of Medicine 
Professor of Medicine, Weill Cornell Medical College

Wungki Park, MD, MS
Assistant Attending
Gastrointestinal Oncology Service 
Department of Medicine
Assistant Professor, Weill Cornell Medical College

Alice Wei, MD, MSc, FRCSC, FACS
Attending Surgeon
Hepatopancreatobiliary Service 
Department of Surgery 
Associate Professor of Surgery, 
Weill-Cornell School of Medicine

 

Relevant Financial Relationships

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.